Searched for
HEAD OF RESEARCH AT INDIANIVESH
Zero-budget farming may not be a good move for fertiliser companies: Experts"Negative for fertilizer companies as zero-budget farming significantly cuts down on agri-input consumption, Mr. Aksh Vashisth, analyst- ch...- As Samvat 2075 ends for market, Dalal Street rates its show poorlyEquity market performance on the larger or broader scale was disappointing in Samvat 2075.
- Affordable housing trends on D-Street tooCompanies like Gruh Finance and DHFL, which provide loans to affordable housing for the middle and low income segments, rose up to 8%.
- Buy Balrampur Chini, target Rs 140: Daljeet Singh Kohli"After the March quarter results, sugar sector has shown a very good set of numbers. In the space, we like
- Chennai floods to hit IT firms; Cement, roads sectors to pick up: Daljeet Singh Kohli, IndiaNivesh"What is important to watch out for is what will happen the manufacturing side."
- See 50-60% upside potential in Majesco: Daljeet Singh KohliWe have a buy rating on the stock with a target of Rs 549; we reiterate that Majesco is a long-term investment, says Kohli.
- See no arbitrage opportunity in IDFC; better wait for demerger: Daljeet Singh KohliIf you are buying IDFC due to the banking trigger, then let the NBFC commence banking operations first, says Kohli.
- Don't prefer SKS Microfinance on stretched valuations, looming regulatory concerns:'You should buy it only bargain'
- Investors are in the buying mode: Daljeet Singh Kohli, IndiaNivesh Ltd"They were all cautious. One would say that one will have to look at their numbers and a little bit of confidence was shaking."
- OMCs can be trading, not investment bets: Daljeet Singh Kohli, IndiaNivesh Ltd"We do not take a call on them as an investment bets, so with the oil and gas space, we always stick to upstream companies."
- Prefer Torrent Pharma in midcap pharma space; see stock at Rs 1,677: Daljeet Singh KohliTorrent Pharma Q1 numbers were ahead of expectations, although some people have raised questions over what is next, says Kohli.
- Bullish on Tata Global Beverages despite recent fall: Daljeet Singh Kohli, IndiaNivesh LtdThe current fall could be because someone holding it would have lost the patience or money would be required for some other purposes.
- Risk-averse investors should prefer Sun Pharma over SPARC: Daljeet Singh Kohli, IndiaNivesh LtdIf they have to play this group, they should play through Sun Pharma, which has a sustainable business and there is visibility of earnings ...
- Bad debt worries spooking banking stocks; be selective: Daljeet Singh KohliKohi believes that NPAs will see a sharp rise in Q4FY15. He though believes that the problem will start fading away as soon as GDP growth r...
- Rail stocks plunge up to 13% on profit-bookingRail stocks today fell up to 13 per cent on heavy profit booking ahead of the Railway Budget for 2015-16 on Thursday.
- Bullish on Cairn India from valuation perspective; likely to hit Rs 317 in one year: Daljeet Singh Kohli"That gives a lot of comfort and it is also a secondary play on foreign exchange currency. So if the rupee remains around 62-63, it is good...
- Recommend Thomas Cook among other hotel stocks: Daljeet S Kohli"If I have to play tourism theme, then I would rather play with Thomas Cook, Cox & Kings is also highly debt ridden though it is doing well...
- Buy Lumax Auto Technologies and Indoco Remedies: Daljeet S KohliThe rest are reiteration of the previous ones HSIL, we have increased the target price to Rs 485 now from earlier target of Rs 380.
- Should Jindal Steel & Power be bought after 20% fall in two days?JSPL will have to pay retrospective penalty, cash flows will be hit due to purchase of expensive coal and uncertainty for re-allocation of ...
- Aurobindo at a record high, price-to-earnings at 32% discount to peersFor the next fiscal, the stock is trading at 8.7 times to its P/E multiple compared with an average 15.3 times, which is at a 52% discount ...
Load More- Buy Balrampur Chini, target Rs 140: Daljeet Singh Kohli
